Nexalin Technology

Nexalin Technology Cash Flow per Share

The Operating Cash Flow per Share of Nexalin Technology (NXL) as of Oct 18, 2026 is -7.99 USD. In the previous year, Operating Cash Flow per Share was -12.84 USD — a change of -37.80% (higher).

Cash Flow per Share

-7.99USD

YoY

-37.80%

Last updated:

Operating Cash Flow per Share of Nexalin Technology is 2025 -7.99 USD. Operating Cash Flow per Share of Nexalin Technology was 2024 -12.84 USD. It decreases by -37.80% higher compared to the previous year.

The Nexalin Technology Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2019
-0.96 USD
Jan 1, 2020
-6.18 USD
Jan 1, 2021
-6.90 USD
Jan 1, 2022
-9.12 USD
Jan 1, 2023
-15.47 USD
Jan 1, 2024
-12.84 USD
Jan 1, 2025
-7.99 USD
The Nexalin Technology Cash Flow per Share history
YEARCash Flow per ShareYoY
-7.99USD-37.80%
-12.84USD-17.01%
-15.47USD+69.61%
-9.12USD+32.15%
-6.90USD+11.75%
-6.18USD+541.75%
-0.96USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nexalin Technology Stock analysis

What does Nexalin Technology do? Nexalin Technology Inc, headquartered in Laguna Niguel, California, designs and develops neurostimulation products within the US health care sector. Listed on September 16, 2022, the company employs six full-time staff members. Its flagship device, Generation 1, utilizes bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The non-invasive system applies a high-frequency, charge-balanced electrical current waveform via head electrodes, offering relief without adverse side effects. Additionally, Nexalin is designing clinical trials for Generation 2, targeting substance use disorders, particularly opiate abuse, as well as chronic pain, Alzheimer’s disease, and dementia. These devices operate using varying voltages and frequencies to address mental health issues effectively. Nexalin Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nexalin Technology stock

Operating Cash Flow per Share of Nexalin Technology is -7.99 USD in 2025.

Operating Cash Flow per Share of Nexalin Technology changed from -12.84 USD to -7.99 USD, representing a -37.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Nexalin Technology since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Nexalin Technology

All Key Metrics — Nexalin Technology